Table 4.
Antiarrhythmic Medications Used With Cardioversion
| AF+HF (N=14 434) | AF+HFrEF (N=4776) | PINNACLE AATAC Eligible Cohort (N=1113) | |
|---|---|---|---|
| Amiodarone | 4073 (28.2%) | 1769 (37.0%) | 410 (36.8%) |
| Dofetilide | 181 (1.3%) | 79 (1.7%) | 26 (2.3%) |
| Dronedarone | 542 (3.8%) | 112 (2.3%) | 15 (1.3%) |
| Flecainide | 99 (0.7%) | 11 (0.2%) | 1 (0.1%) |
| Propafenone | 52 (0.4%) | 8 (0.2%) | 2 (0.2%) |
| Quinidine | 3 (0.0%) | 1 (0.0%) | 0 (0.0%) |
| Sotalol | 241 (1.7%) | 88 (1.8%) | 26 (2.3%) |
AF indicates atrial fibrillation; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; PINNACLE, Practice Innovation and Clinical Excellence.